Subscribe to Newsletter

Clinical Trials

Discovery & Development Clinical Trials

The Role of Data in Drug Development

| Daniel Chancellor | 4 min read

How connecting the data dots can lead to better development and clinical trals. 

Discovery & Development Clinical Trials

A Shared Vision for Global Health

| 2 min read

Not all patients are able to reap the benefits of groundbreaking new therapeutics. The industry must do more.

Discovery & Development Clinical Trials

AI in Oncology: The Bridge Between the Patient and the Practice

| 2 min read

Using AI to improve oncology care and find the right clinical trials for patients.

Discovery & Development Clinical Trials

Asking the Right Questions in R&D

| 3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Discovery & Development Clinical Trials

Why Reducing Complexity Can Lead to Better Clinical Trials

| 6 min read

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Business & Regulation Trends & Forecasts

The Clinical Trials of 2025

| Elisa Cascade, Pamela Tenaerts | 4 min read

As 2024 draws to its conclusion, two experts look at trends in clinical trials and form predictions for 2025.

Discovery & Development Drug Discovery

Takeda’s Chinwe Ukomadu and Chris Arendt on Biopharma’s Future

| 3 min read

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

Discovery & Development Clinical Trials

Getting to First-in-Human Fast

| Asma Patel | 3 min read

How to meet the demand for first-in-human clinical trials using fit-for-phase formulation approaches.

Discovery & Development Clinical Trials

Breaking Bottlenecks in Clinical Trials

| 3 min read

From regulatory hurdles to patient recruitment challenges; how can pharma improve its clinical trials?

Discovery & Development Clinical Trials

Moldova-based HBV Gene Editing Trial: A Trial of Our Times

| Rob Coker

An HBV gene editing clinical trial has been approved in Moldova, but the challenges go beyond science and industry.


Latest White Papers

Accelerate recruitment with a decentralized clinical trial strategy

| Contributed by Thermo Fisher Scientific

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register